Coatings, devices and methods are provided, wherein the contacting surface of a medical device with at least one contacting surface for contacting a bodily fluid or tissue, wherein long-lasting and durable bioactive agents or functional groups are deposited on the contacting surface through a unique
Coatings, devices and methods are provided, wherein the contacting surface of a medical device with at least one contacting surface for contacting a bodily fluid or tissue, wherein long-lasting and durable bioactive agents or functional groups are deposited on the contacting surface through a unique two-step plasma coating process with deposition of a thin layer of plasma coating using a silicon-containing monomer in the first step and plasma surface modification using a mixture of nitrogen-containing molecules and oxygen-containing molecules in the second step. The two-step plasma coating process enables the implantable medical device to prevent both restenosis and thrombosis under clinical conditions. The invention also relates to surface treatment of metallic and polymeric biomaterials used for making of medical devices with significantly improved clinical performance and durability.
대표청구항▼
1. A method of making a medical device adapted for implantation into a human or animal host wherein the medical device comprises at least one contacting surface for contacting a bodily fluid or tissue, the method comprising: (a) depositing a plasma coating of less than 100 nm thickness on the at lea
1. A method of making a medical device adapted for implantation into a human or animal host wherein the medical device comprises at least one contacting surface for contacting a bodily fluid or tissue, the method comprising: (a) depositing a plasma coating of less than 100 nm thickness on the at least one contacting surface using a silicon-containing monomer selected from trimethylsilane (TMS), vinyltrichlorosilane, tetraethoxysilane, vinyltriethoxysilane, hexamethyldisilazane, tetramethylsilane, vinyldimethylethoxysilane, vinyltrimethoxysilane, tetravinylsilane, vinyltriacetoxysilane, or methyltrimethoxysilane to produce a plasma surface; and(b) covalently bonding nitric oxide functional groups to the plasma surface using a plasma comprising a mixture of nitrogen-containing and oxygen-containing molecules. 2. The method of claim 1 wherein the nitrogen-containing molecules each comprise no more than six atoms. 3. The method of claim 1 wherein the nitrogen-containing molecules each comprise no more than four atoms. 4. The method of claim 1 wherein the nitrogen-containing molecules comprise NH3, NH4, N2O, NO, NO2, or N2O4. 5. The method of claim 1 wherein the oxygen-containing molecules comprise O2 or O3. 6. The method of claim 1 wherein the medical device is a stent and wherein the at least one contacting surface comprises the lumen of the stent. 7. The method of claim 1 wherein the silicon-containing monomer is (CH3)3—SiH. 8. The method of claim 1 wherein the medical device is selected from stents, catheters, balloons, shunts, grafts, valves, pacemakers, pulsed generators, cardiac defibrillators, spinal stimulators, brain stimulators, leads, screws, and sensors. 9. A method of making a medical device adapted for implantation into a human or animal host wherein the medical device comprises at least one contacting surface for contacting a bodily fluid or tissue, the method comprising: (a) depositing a first plasma coating of less than 100 nm thickness on the contacting surface using a silicon-containing monomer selected from trimethylsilane (TMS), vinyltrichlorosilane, tetraethoxysilane, vinyltriethoxysilane, hexamethyldisilazane, tetramethylsilane, vinyldimethylethoxysilane, vinyltrimethoxysilane, tetravinylsilane, vinyltriacetoxysilane, or methyltrimethoxysilane to produce a first plasma surface; and(b) depositing a second plasma coating on the first plasma coating using a mixture of nitrogen-containing and oxygen-containing molecules, thereby covalently bonding nitric oxide functional groups to the first plasma surface and resulting in a plasma-modified contacting surface. 10. The method of claim 9, wherein the plasma-modified contacting surface exhibits increased adhesion of at least some mammalian cells compared to a similar contacting surface that is not plasma-modified. 11. The method of claim 9, wherein the plasma-modified contacting surface exhibits decreased restenosis subsequent to placement in blood vessel compared to a similar stent that is not plasma-modified. 12. The method of claim 9, wherein the medical device is a stent and wherein the at least one contacting surface comprises the lumen of the stent. 13. The method of claim 9, wherein the first plasma coating thickness is less than 60 nm. 14. The method of claim 9, wherein the first plasma coating thickness is less than 20 nm. 15. The method of claim 9, wherein the first plasma coating thickness is between 10 and 20 nm. 16. The method of claim 9, wherein the first plasma coating is deposited in less than about 10 minutes. 17. The method of claim 9, wherein the silicon-containing monomer is trimethylsilane (TMS). 18. The method of claim 9, wherein the plasma is fabricated by a glow discharge plasma deposition process. 19. The method of claim 9, wherein the contacting surface is a metallic or polymeric surface. 20. The method of claim 9, wherein the medical device is selected from stents, catheters, balloons, shunts, grafts, valves, pacemakers, pulsed generators, cardiac defibrillators, spinal stimulators, brain stimulators, leads, screws, and sensors.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (27)
Athanasiou Kyriacos A. ; Boyan Barbara D., Biodegradable implant.
Chatelier Ronald C. (9 Apple Gve Bayswater ; Victoria 3168 AUX) Griesser Hans J. (20 View Road The Patch ; Victoria 3792 AUX) Steele John G. (7 The Carriageway North Rocks ; NSW 2151 AUX) Johnson Gra, Cell growth substrates.
Georger ; Jr. Jacque H. (Springfield VA) Stenger David A. (Reston VA) Fare Thomas L. (Washington DC), Deep ultraviolet photolithographically defined ultra-thin films for selective cell adhesion and outgrowth and method of.
Winters Suzanne (Salt Lake City UT) Solen Kenneth A. (Orem UT) Sanders Clifton G. (Salt Lake City UT) Mortensen JD (Sandy UT) Berry Gaylord (Salt Lake City UT), Gas permeable thrombo-resistant coatings and methods of manufacture.
Hu Chen-Ze (Salt Lake City UT) Dolence Eric K. (Salt Lake City UT) Osaki Shigemasa (Sandy UT) Sanders Clifton G. (Salt Lake City UT), Hydrocyclosiloxane membrane prepared by plasma polymerization process.
Rosen Gerald M. ; Herzog ; Jr. William R. ; Pou Sovitj, Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosy.
Rosen Gerald M. (Lutherville MD) Herzog ; Jr. William R. (Baltimore MD) Pou Sovitj (Baltimore MD), Nitric oxide-releasing nitroso compositions and methods and intravascular devices for using them to prevent restenosis.
Keefer Larry K. ; Hrabie Joseph A., Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods o.
Hostettler Fritz (Lambertville NJ) Rhum David (New York NY) Forman Michael R. (Ramsey CA) Helmus Michael N. (St. Louis Park MN) Ding Ni (Plymouth MN), Process for producing slippery, tenaciously adhering hydrogel coatings containing a polyurethane-urea polymer hydrogel c.
Berneron Roger (Gargenville FRX) de Gelis Pierre (Saint Germain en Laye FRX), Process for the improvement of the corrosion resistance of metallic materials.
Hostettler Fritz ; Rhum David ; Forman Michael R. ; Helmus Michael N. ; Ding Ni, Slippery, tenaciously adhering hydrogel coatings containing a polyurethane-urea polymer hydrogel commingled with a pol.
Hostettler Fritz ; Rhum David ; Forman Michael R. ; Helmus Michael N. ; Ding Ni, Slippery, tenaciously adhering hydrophilic polyurethane hydrogel coatings, coated polymer substrate materials, and coated medical devices.
Narayanan Pallassana V. (Davie FL) Rowland Stephen M. (Miami FL) Stanley Kimberly D. (Miami FL), Treatment of metallic surfaces using radiofrequency plasma deposition and chemical attachment of bioactive agents.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.